Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines

被引:66
作者
Szardenings, AK [1 ]
Antonenko, V [1 ]
Campbell, DA [1 ]
DeFrancisco, N [1 ]
Ida, S [1 ]
Shi, LH [1 ]
Sharkov, N [1 ]
Tien, D [1 ]
Wang, YW [1 ]
Navre, M [1 ]
机构
[1] Affymax Res Inst, Santa Clara, CA 95051 USA
关键词
D O I
10.1021/jm980475p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Thiol-containing diketopiperazines have been recently identified as novel heterocyclic inhibitors of matrix metalloproteinase (MMPs). The compounds described had similar activities against the MMPs collagenase-1 and gelatinase-B. An inhibitor that showed greater than 10-fold selectivity for collagenase-1 over gelatinase-B was desired. Previously published work with peptidyl hydroxamates and thiols indicated that while preparing gelatinase selective inhibitors was straightforward, there was not an obvious route to selective inhibitors of collagenase-1. Combinatorial libraries were prepared and evaluated for their ability to inhibit collagenase-1 and gelatinase-B substrate hydrolysis. A method for estimating the IC50 values of compounds generated by high-throughput parallel synthesis aided in the identification of compounds with the desired properties. We have found that thiol diketopiperazines derived from nitrophenylalanine are both potent and selective inhibitors of collagenase-1. In addition, we have demonstrated that combinatorial chemistry can be utilized to identify molecules with a desired selectivity profile without access to the traditional tools of rational drug design.
引用
收藏
页码:1348 / 1357
页数:10
相关论文
共 32 条
  • [1] ANTONENKO VA, 1998, IN PRESS COMBINATORI
  • [2] Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
    Billinghurst, RC
    Dahlberg, L
    Ionescu, M
    Reiner, A
    Bourne, R
    Rorabeck, C
    Mitchell, P
    Hambor, J
    Diekmann, O
    Tschesche, H
    Chen, J
    VanWart, H
    Poole, AR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) : 1534 - 1545
  • [3] STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
    BORKAKOTI, N
    WINKLER, FK
    WILLIAMS, DH
    DARCY, A
    BROADHURST, MJ
    BROWN, PA
    JOHNSON, WH
    MURRAY, EJ
    [J]. NATURE STRUCTURAL BIOLOGY, 1994, 1 (02): : 106 - 110
  • [4] Matrix metalloproteinase inhibitors in arthritis
    Bottomley, KM
    Johnson, WH
    Walter, DS
    [J]. JOURNAL OF ENZYME INHIBITION, 1998, 13 (02): : 79 - 101
  • [5] Design and synthesis of the cartilage protective agent (CPA, Ro32-3555)
    Broadhurst, MJ
    Brown, PA
    Lawton, G
    Ballantyne, N
    Borkakoti, N
    Bottomley, KMK
    Cooper, MI
    Eatherton, AJ
    Kilford, IR
    Malsher, PJ
    Nixon, JS
    Lewis, EJ
    Sutton, BM
    Johnson, WH
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (17) : 2299 - 2302
  • [6] Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases
    Cawson, T
    [J]. MOLECULAR MEDICINE TODAY, 1998, 4 (03): : 130 - 137
  • [7] Metalloproteinase inhibitors and the prevention of connective tissue breakdown
    Cawston, TE
    [J]. PHARMACOLOGY & THERAPEUTICS, 1996, 70 (03) : 163 - 182
  • [8] Davidson AH, 1997, CHEM IND-LONDON, P258
  • [9] Matrix metalloproteinase inhibitors: Present achievements and future prospects
    Denis, LJ
    Verweij, J
    [J]. INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) : 175 - 185
  • [10] Discovery of enzyme inhibitors through combinatorial chemistry
    Dolle, RE
    [J]. MOLECULAR DIVERSITY, 1997, 2 (04) : 223 - 236